3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole
Suppliers
Names
[ CAS No. ]:
150405-69-9
[ Name ]:
3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole
[Synonym ]:
3-(4-Biphenylyl)-5-[4-(2-methyl-2-propanyl)phenyl]-4-phenyl-4H-1,2,4-triazole
4H-1,2,4-Triazole, 3-[1,1'-biphenyl]-4-yl-5-[4-(1,1-dimethylethyl)phenyl]-4-phenyl-
3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole
3-(4-tert-butylphenyl)-4-phenyl-5-(4-phenylphenyl)-1,2,4-triazole
3-(4-BiPhenyl)-4-Phenyl-5-Tert-butylPhenyl-1,2,4-Triazole
Chemical & Physical Properties
[ Density]:
1.1±0.1 g/cm3
[ Boiling Point ]:
611.5±58.0 °C at 760 mmHg
[ Melting Point ]:
231-235 ℃
[ Molecular Formula ]:
C30H27N3
[ Molecular Weight ]:
429.556
[ Flash Point ]:
323.6±32.3 °C
[ Exact Mass ]:
429.220490
[ PSA ]:
30.71000
[ LogP ]:
9.55
[ Vapour Pressure ]:
0.0±1.8 mmHg at 25°C
[ Index of Refraction ]:
1.615
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H302
[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Faceshields;Gloves
[ Hazard Codes ]:
Xn
[ Risk Phrases ]:
22
[ RIDADR ]:
NONH for all modes of transport
Articles
PLoS ONE 10(2) , e0118336, (2015)
Oncogenic transformation is characterized by morphological changes resulting from alterations in actin dynamics and adhesive activities. Emerging evidence suggests that the protocadherin FAT4 acts as ...
Oncotarget 5(23) , 12166-76, (2015)
Triple-negative breast cancer (TNBC) accounts for approximately 15-20% of all breast cancer (BC) cases and contributes disproportionately to BC mortality. TAZ, a key transducer of the Hippo pathway, h...
Cell Cycle 14(1) , 146-56, (2015)
The Hippo pathway is an evolutionarily conserved regulator of tissue growth and cell fate during development and regeneration. Conversely, deregulation of the Hippo pathway has been reported in severa...